Sonoma Pharmaceuticals (SNOA) EPS (Diluted) Growth (3y) (2016 - 2026)
Sonoma Pharmaceuticals (SNOA) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.12% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.26% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.43% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.24% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.96% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.19% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.62% |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | 96.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 96.45% |
| Dec 31, 2025 | 96.63% |
| Sep 30, 2025 | 96.33% |
| Jun 30, 2025 | 49.06% |
| Sep 30, 2024 | 11.57% |
| Jun 30, 2024 | 49.61% |
| Mar 31, 2024 | 89.80% |
| Dec 31, 2023 | 81.04% |
| Sep 30, 2023 | -2,615.76% |
| Jun 30, 2023 | -723.99% |
| Mar 31, 2023 | -3,290.51% |
| Dec 31, 2022 | -1,770.06% |
| Sep 30, 2022 | -1,619.62% |
| Jun 30, 2022 | -124.54% |
| Sep 30, 2021 | 77.55% |
| Jun 30, 2021 | 53.03% |
| Mar 31, 2020 | -78.89% |
| Dec 31, 2019 | -85.73% |
| Sep 30, 2019 | -67.53% |
| Jun 30, 2019 | -73.73% |